Scientist have researched and developed immunotherapy, which is an efficient way of treating the condition. According to Lindbergh (119), Aplastic anemia refers to a both serious and rare anemic condition that has been traced back to the late 1880s and was considered to be a fatal condition to almost half of the people suffering with it, with little or no regards to the treatment. However, through science and scientific studies, the immunosuppressive therapy was developed, and coupled with other treatment plans has improved the survival rates of patients considerably. Currently, over 60 percent of individuals suffering from Aplastic anemia undergo successful treatment of the condition and respond positively to …show more content…
According to Yale University, a novel gene edition technique has been used and has effectively corrected mutations that bring about a kind of anemia known as thalassemia (“Scientists edit gene mutations in inherited form of anaemia” n.p.). The gene editing method used by the scientist has offered corrections with regards to mutations, over and above alleviating the condition in mice. More studies will have to be conducted before the treatment will be available for humans. The University’s research team has acknowledged that a specific protein in the bone marrow and has the ability to trigger the production of stem cells. Their search team combined the protein with some synthetic molecules called PNAs, which imitate DNA and attaches itself to the target gene to develop a triple helix (Lindbergh 145-148). This sets off a chain reaction in the cell’s individual repair process that fixes the mutation responsible for causing the